FINWIRES · TerminalLIVE
FINWIRES

Cynata Says WHO Selects Generic Name for Cymerus Mesenchymal Stem Cells

By

Cynata Therapeutics (ASX:CYP) said the World Health Organization (WHO) selected pixenstrocel as the proposed generic name for Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSC), according to a Friday Australian bourse filing.

The proposed generic name is expected to be published in 2027 in the WHO Drug Information List 136 of Proposed International Nonproprietary Name, the company said. The final confirmation is expected around May 2027.

The generic name represents the active agent in iPSC-derived MSC products.

Related Articles

Asia

Standard Chartered to Issue $1 Billion in Debt

Standard Chartered (HKG:2888) plans to issue $1.00 billion in bonds, according to a Friday filing with the Hong Kong bourse.The lender plans to issue the debt in the form of fixed-rate resetting perpetual subordinated contingent convertible securities that will be listed in London and Hong Kong. Issuance is expected to take place June 8.The bonds will offer interest at an initial rate of 7% and convert into shares of Standard Chartered at the rate of $26.379 per share.Funds raised will be used for general business purposes, the bank said.

$HKG:2888
Asia

Western Australia Supreme Court to Hear Application Related to Genesis Materials' Takeover of Magnetic Resources

Magnetic Resources (ASX:MAU) said the Supreme Court of Western Australia will hear an application by the firm on June 9, seeking the approval of its members of a scheme of arrangement under which Genesis Minerals (ASX:GMD) proposes to acquire 100% of the shares in Magnetic, according to a Friday Australian bourse filing.Members seeking to oppose the application must file with the court and serve on Magnetic a notice of appearance, together with any affidavit they wish to present at the hearing.

$ASX:GMD$ASX:MAU
Asia

ASX Preview: Australian Shares Set to Rise as Oil Falls on US-Iran Ceasefire Signal; Dexus Requests Trading Halt Ahead of Court Decision

Australian shares are poised to rise on Friday as oil prices fell after reports that the US and Iran had agreed in principle to extend a ceasefire and reopen shipping through the Strait of Hormuz, easing fears of supply disruption even as officials said the deal had yet to be finalized.Overnight, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average rose 0.6%, 0.9%, and 0.1%, respectively.In the macroeconomy, the Reserve Bank of Australia's housing and private sector credit report is due at 11:30 am Sydney time.In corporate news, Dexus (ASX:DXS) requested a trading halt on the Australian Securities Exchange from Friday, pending a New South Wales Supreme Court decision.Insurance Australia Group (ASX:IAG) said its subsidiary, Insurance Australia, has reached a confidential settlement with Greensill Bank and its insolvency administrator, resolving Federal Court proceedings relating to allegedly issued trade credit insurance policies.Australia's benchmark index fell 1.4% or 124.8 points to close at 8,592.90 on Thursday.

$^AXJO$ASX:DXS$ASX:IAG